Sectors & Industries HealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2025)
Top pharmaceutical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical stocks to buy now. Learn More.

Industry: Drug Manufacturers - Spec...

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Pharmaceutical is Zen Rated B and is the 46th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PAHC	PHIBRO ANIMAL HEALTH CORP	$1.07B	12.40%	2.80%	7.74%	5.90%	3.95	2.91	31.70%	2.70%	6.83%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$51.62M	-12.80%	-4.40%	-5.98%	-9.20%	1.45	1.25	84.30%	-8.00%	-6.46%
AMRX	AMNEAL PHARMACEUTICALS INC	$2.45B	N/A	-0.40%	11.46%	7.40%	-26.56	1.40	36.70%	-0.50%	9.27%
KMDA	KAMADA LTD	$424.96M	6.30%	4.40%	5.72%	14.90%	0.49	3.30	44.20%	9.60%	10.88%
INDV	INDIVIOR PLC	$2.52B	-1.50%	0.20%	14.32%	15.70%	-5.83	0.88	80.40%	0.30%	4.53%
NBIX	NEUROCRINE BIOSCIENCES INC	$12.72B	13.20%	9.40%	15.76%	15.90%	0.44	3.20	98.50%	13.90%	21.00%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$17.72B	-2.60%	-0.40%	3.19%	4.00%	4.88	1.06	49.60%	-1.00%	5.42%
HCM	HUTCHMED (CHINA) LTD	$3.10B	5.10%	3.00%	5.32%	6.30%	0.66	2.83	44.60%	6.00%	7.58%
ANIP	ANI PHARMACEUTICALS INC	$1.37B	-5.40%	-1.90%	-0.83%	-1.00%	2.03	2.66	59.30%	-3.40%	-1.35%
AYTU	AYTU BIOPHARMA INC	$15.06M	5.30%	1.40%	18.88%	993.50%	2.56	1.03	68.60%	2.40%	14.59%
BHC	BAUSCH HEALTH COMPANIES INC	$2.18B	-8.90%	0.40%	8.12%	7.10%	-35.50	1.31	70.70%	1.00%	18.35%
COLL	COLLEGIUM PHARMACEUTICAL INC	$959.77M	19.20%	2.90%	12.45%	18.20%	5.96	1.08	57.70%	6.60%	21.45%
EBS	EMERGENT BIOSOLUTIONS INC	$319.15M	-27.30%	-9.10%	-0.07%	-0.10%	1.58	6.32	35.20%	-13.60%	-0.09%
ELAN	ELANCO ANIMAL HEALTH INC	$6.79B	6.00%	2.80%	6.38%	9.70%	1.04	2.71	54.90%	8.40%	16.83%
ETON	ETON PHARMACEUTICALS INC	$379.74M	-23.40%	-8.00%	-3.86%	-14.50%	2.44	1.97	59.40%	-9.30%	-4.59%
AVDL	AVADEL PHARMACEUTICALS PLC	$1.02B	-36.10%	-16.30%	-13.84%	-17.20%	1.27	2.73	90.10%	-13.60%	-8.33%
PCRX	PACIRA BIOSCIENCES INC	$976.57M	-12.90%	-6.60%	-3.95%	-4.10%	0.99	2.42	77.60%	-14.80%	-7.14%
IMCC	IM CANNABIS CORP	$8.08M	-74.40%	-10.40%	-20.60%	-8.40%	7.84	0.72	18.60%	-8.10%	-1.57%
SUPN	SUPERNUS PHARMACEUTICALS INC	$1.97B	6.10%	4.60%	8.62%	25.30%	0.31	2.44	88.40%	9.30%	13.74%
PRGO	PERRIGO CO PLC	$3.67B	-4.10%	-1.80%	2.24%	3.10%	1.24	2.36	36.40%	-4.20%	4.48%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$3.65B	12.20%	6.40%	10.07%	23.80%	0.85	4.21	55.80%	18.90%	29.16%
DERM	JOURNEY MEDICAL CORP	$171.22M	-52.00%	-11.30%	-11.62%	-35.00%	2.94	1.34	66.50%	-14.80%	-9.24%
ZTS	ZOETIS INC	$64.91B	51.30%	17.70%	31.80%	26.70%	2.03	1.74	70.90%	27.10%	36.69%
ALKS	ALKERMES PLC	$4.37B	23.70%	16.30%	24.13%	31.70%	0.39	3.23	85.10%	23.10%	28.00%
HLN	HALEON PLC	$42.83B	8.80%	4.20%	7.64%	20.40%	1.12	0.98	60.70%	12.80%	19.40%
BGM	BGM GROUP LTD	$61.14M	-2.40%	-2.10%	-3.78%	-20.90%	0.13	1.82	19.40%	-10.10%	-25.89%
ALVO	ALVOTECH	$2.73B	-23.20%	8.10%	26.10%	13.80%	-5.12	1.73	60.70%	16.40%	43.49%
TKNO	ALPHA TEKNOVA INC	$241.55M	-28.50%	-19.70%	-21.17%	-19.10%	0.45	5.64	21.00%	-60.90%	-59.19%
CRON	CRONOS GROUP INC	$763.13M	4.60%	4.30%	-0.12%	-0.60%	0.04	27.80	27.70%	39.70%	-1.07%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$42.86B	1.90%	0.90%	3.77%	5.50%	1.04	1.16	64.80%	3.10%	9.96%
LNTH	LANTHEUS HOLDINGS INC	$4.93B	22.80%	12.70%	20.80%	34.40%	0.77	5.74	64.00%	16.50%	24.46%
IRWD	IRONWOOD PHARMACEUTICALS INC	$123.63M	N/A	-8.80%	20.72%	6.90%	-1.98	3.34	100.00%	-10.20%	18.21%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$987.56M	19.40%	9.10%	14.07%	15.90%	1.17	2.95	50.50%	19.40%	27.48%
QNTM	QUANTUM BIOPHARMA LTD	$63.63M	-187.80%	-126.00%	-452.73%	-1,061.10%	1.80	0.96	N/A	N/A	N/A
VTRS	VIATRIS INC	$10.26B	-20.60%	-8.90%	-10.37%	-14.20%	1.46	1.68	36.90%	-26.40%	-23.71%
DVAX	DYNAVAX TECHNOLOGIES CORP	$1.32B	-9.80%	-6.00%	-5.55%	-4.40%	0.78	11.93	82.30%	-20.40%	-16.54%
UPC	UNIVERSE PHARMACEUTICALS INC	$1.99M	2.70%	1.70%	2.27%	5.90%	0.46	2.78	30.40%	5.60%	6.74%
SIGA	SIGA TECHNOLOGIES INC	$472.23M	25.20%	22.10%	28.40%	97.70%	0.14	8.40	76.50%	40.30%	51.76%
CTOR	CITIUS ONCOLOGY INC	$158.13M	-74.20%	-32.90%	-60.35%	-59.00%	1.57	0.36	N/A	N/A	N/A
ORGO	ORGANOGENESIS HOLDINGS INC	$586.06M	-7.80%	-4.40%	-6.01%	-7.70%	0.41	4.12	75.90%	-4.50%	-5.27%
EOLS	EVOLUS INC	$575.12M	-932.00%	-24.70%	-23.59%	-25.40%	-33.31	2.34	68.10%	-20.40%	-13.46%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$6.53B	-42.50%	-40.90%	-52.18%	-52.80%	0.03	41.92	N/A	N/A	N/A
IXHL	INCANNEX HEALTHCARE INC	$17.22M	-332.20%	-144.00%	-242.50%	-406.10%	1.19	2.12	100.00%	-22,186.70%	-21,846.94%
OGI	ORGANIGRAM GLOBAL INC	$179.34M	5.20%	3.80%	3.68%	7.00%	0.38	3.42	32.70%	8.80%	8.76%
RMTI	ROCKWELL MEDICAL INC	$31.78M	-0.90%	-0.50%	1.96%	2.60%	0.71	2.95	17.90%	-0.30%	0.86%
HROW	HARROW INC	$1.17B	-35.80%	-6.10%	1.35%	1.10%	5.46	0.91	74.50%	-10.20%	1.12%
RDY	DR REDDYS LABORATORIES LTD	$11.87B	18.40%	12.80%	21.76%	28.70%	0.47	1.92	58.50%	17.40%	24.24%
EVO	EVOTEC SE	$1.41B	N/A	N/A	N/A	N/A	1.13	2.03	N/A	N/A	N/A
KALA	KALA BIO INC	$43.68M	-369.30%	-65.00%	-119.60%	-154.90%	7.45	1.99	N/A	N/A	N/A
BIOA	BIOAGE LABS INC	$157.74M	N/A	N/A	N/A	N/A	0.10	13.68	N/A	N/A	N/A
SXTC	CHINA SXT PHARMACEUTICALS INC	$21.47M	-22.50%	-14.80%	-16.97%	-162.40%	0.40	3.54	32,034.00%	-76,811.30%	-61,739.85%
ACB	AURORA CANNABIS INC	$249.12M	0.00%	0.00%	1.79%	2.40%	0.43	4.32	54.60%	0.10%	3.87%
CRDL	CARDIOL THERAPEUTICS INC	$123.09M	-210.20%	-141.50%	-202.13%	580.00%	0.45	3.26	N/A	N/A	N/A
LFCR	LIFECORE BIOMEDICAL INC	$259.18M	-788.60%	-19.90%	-10.94%	-7.10%	85.36	2.71	33.40%	-37.90%	-17.34%
ASRT	ASSERTIO HOLDINGS INC	$68.58M	-24.90%	-10.90%	-17.39%	-31.80%	1.64	1.66	69.90%	-25.70%	-23.03%
ESPR	ESPERION THERAPEUTICS INC	$281.44M	N/A	-45.90%	-166.90%	-16.20%	-1.76	1.18	65.30%	-59.00%	-34.12%
CGC	CANOPY GROWTH CORP	$190.75M	-112.80%	-52.00%	-71.78%	-51.70%	0.88	3.12	29.60%	-222.40%	-219.70%
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$1.60M	-1,202.90%	-370.40%	-276.22%	-2,354.50%	0.62	2.78	N/A	N/A	N/A
TLRY	TILRAY BRANDS INC	$639.41M	-78.20%	-62.80%	-126.97%	-192.70%	0.39	2.46	29.30%	-266.30%	-277.34%
AQST	AQUESTIVE THERAPEUTICS INC	$381.42M	N/A	-50.30%	-44.51%	-27.70%	-2.68	4.87	68.40%	-100.00%	-68.89%
YCBD	CBDMD INC	$7.99M	-223.80%	-35.50%	-15.67%	-418.80%	15.43	0.63	62.40%	-21.20%	-0.85%
SNOA	SONOMA PHARMACEUTICALS INC	$4.90M	-70.50%	-25.30%	-30.29%	-49.10%	2.10	3.09	38.20%	-24.20%	-20.35%
GELS	GELTEQ LTD	$16.33M	N/A	N/A	N/A	N/A	0.34	0.79	N/A	N/A	N/A
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-40.20%	349.59%	139.50%	-4.85	0.54	60.30%	-102.80%	-181.69%
DRRX	DURECT CORP	$58.05M	-94.80%	-22.70%	-81.38%	-1,352.00%	1.68	1.23	140.20%	-935.80%	-1,036.57%
CPHI	CHINA PHARMA HOLDINGS INC	$5.58M	-63.70%	-32.10%	-48.66%	-63.50%	1.04	0.56	-42.60%	-106.30%	-103.04%
SCYX	SCYNEXIS INC	$26.92M	-48.30%	-29.70%	-45.23%	-42.40%	0.34	5.83	100.00%	-1,030.00%	-1,013.99%
SBFM	SUNSHINE BIOPHARMA INC	$6.56M	-21.20%	-16.90%	-22.71%	-45.20%	0.29	4.25	30.50%	-13.90%	-14.68%
TLPH	TALPHERA INC	$8.61M	-129.50%	-58.90%	-89.52%	-83.50%	1.68	3.11	100.00%	-43,122.20%	-43,122.22%
INCR	INTERCURE LTD	$67.44M	-15.90%	-8.80%	-6.19%	-7.70%	0.92	1.73	12.70%	-28.40%	-13.88%
FLGC	FLORA GROWTH CORP	$13.27M	-255.80%	-49.30%	-136.08%	-333.10%	3.71	1.05	21.70%	-25.00%	-25.05%
BFRI	BIOFRONTERA INC	$10.20M	-216.00%	-58.50%	-191.37%	-142.60%	34.37	1.40	53.30%	-30.30%	-28.35%
EVOK	EVOKE PHARMA INC	$5.42M	-101.90%	-33.80%	-77.28%	289.90%	1.80	1.55	97.40%	-43.80%	-39.49%
TXMD	THERAPEUTICSMD INC	$12.96M	-7.70%	-5.40%	-6.45%	-7.20%	0.43	2.64	100.00%	-114.10%	-117.38%
APUS	APIMEDS PHARMACEUTICALS US INC	$20.14M	N/A	N/A	N/A	N/A	-1.15	0.15	N/A	N/A	N/A
AKAN	AKANDA CORP	$2.33M	-1,830.00%	-48.90%	-93.44%	1,757.10%	0.85	1.39	24.90%	-489.60%	-477.60%
PRFX	PAINREFORM LTD	$2.10M	-321.90%	-201.80%	-704.42%	1,140.50%	1.48	1.81	N/A	N/A	N/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best pharma stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 18 points higher than the pharmaceutical industry average of 27.

PAHC passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 40.36% over the past year, overperforming other pharmaceutical stocks by 110 percentage points.

Phibro Animal Health has an average 1 year price target of $27.67, an upside of 4.4% from Phibro Animal Health's current stock price of $26.50.

Phibro Animal Health stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Phibro Animal Health, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) is the #2 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Cumberland Pharmaceuticals (NASDAQ:CPIX) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: C.

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a Due Diligence Score of 30, which is 3 points higher than the pharmaceutical industry average of 27.

CPIX passed 9 out of 33 due diligence checks and has average fundamentals. Cumberland Pharmaceuticals has seen its stock return 141.26% over the past year, overperforming other pharmaceutical stocks by 211 percentage points.

3. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #3 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: B.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 25, which is -2 points lower than the pharmaceutical industry average of 27. Although this number is below the industry average, our proven quant model rates AMRX as a "A".

AMRX passed 8 out of 33 due diligence checks and has weak fundamentals. Amneal Pharmaceuticals has seen its stock return 6.68% over the past year, overperforming other pharmaceutical stocks by 77 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $11.50, an upside of 47.06% from Amneal Pharmaceuticals's current stock price of $7.82.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Dr Reddys Laboratories (NYSE:RDY)

Dr Reddys Laboratories (NYSE:RDY) has an annual dividend yield of N/A, which is N/A percentage points lower than the pharmaceutical industry average of 2.05%. Dr Reddys Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dr Reddys Laboratories's dividend has shown consistent growth over the last 10 years.

Dr Reddys Laboratories's dividend payout ratio of 12.2% indicates that its dividend yield is sustainable for the long-term.

2. Viatris (NASDAQ:VTRS)

Viatris (NASDAQ:VTRS) has an annual dividend yield of 4.12%, which is 2 percentage points higher than the pharmaceutical industry average of 2.05%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of -15.1% indicates that its high dividend yield might not be sustainable for the long-term.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) has an annual dividend yield of 2.71%, which is 1 percentage points higher than the pharmaceutical industry average of 2.05%.

Kamada's dividend payout ratio of 71.4% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -2.32% in the last day, and down -4.33% over the last week. Bausch Health Companies was the among the top losers in the drug manufacturers - specialty & generic industry, dropping -7.82% yesterday.

Bausch Health shares are trading lower after the company reported mixed Q2 adjusted EPS results.

What are the most undervalued pharmaceutical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical stocks right now are:

1. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 38 points higher than the pharmaceutical industry average of 19. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -2.32% in the past year. It has overperformed other stocks in the pharmaceutical industry by 68 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 0, which is -19 points higher than the pharmaceutical industry average of 19. It passed 0 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates IRWD a Valuation Rating of "A".

Ironwood Pharmaceuticals's stock has dropped -88.81% in the past year. It has underperformed other stocks in the pharmaceutical industry by -19 percentage points.

3. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the third most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Collegium Pharmaceutical has a valuation score of 57, which is 38 points higher than the pharmaceutical industry average of 19. It passed 4 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has dropped -22.58% in the past year. It has overperformed other stocks in the pharmaceutical industry by 47 percentage points.

Are pharmaceutical stocks a good buy now?

51.22% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 47.82% over the next year.

13.33% of pharmaceutical stocks have a Zen Rating of A (Strong Buy), 16.67% of pharmaceutical stocks are rated B (Buy), 51.67% are rated C (Hold), 13.33% are rated D (Sell), and 5% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -19.72x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.